Drug Database
Back to search

France· FR:68844504

ORAVERSE 400 microgrammes/1,7 ml, solution injectable

A medicinal product containing mésilate de phentolamine, registered in France by SEPTODONT HOLDING.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedORAVERSE 400 microgrammes/1,7 ml, sol…ATC—REGISTER NO.FR:68844504PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mésilate de phentolamineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
MÉSILATE DE PHENTOLAMINE
Manufacturer
SEPTODONT HOLDING
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400921958355
    10 cartouche(s) en verre de 1,7 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mésilate de phentolamine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mésilate de phentolamine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Spain · Oraverse
  • United Kingdom (Northern Ireland) · Phentolamine Mesilate Roma Pharmaceuticals
  • Italy · Oraverse
  • Netherlands · Regitine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1c6a3760-f94b-4a46-953a-5dbfcc0ff4d6
GET /v1/drugs/1c6a3760-f94b-4a46-953a-5dbfcc0ff4d6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68844504",
  "date_amm": "2012-01-27",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "MÉSILATE DE PHENTOLAMINE",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "dentaire",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about mésilate de phentolamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console